Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Ainhoa Oguiza
ResearcherPublications, citations & collaboration network
Ainhoa Oguiza is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 21 works, 598 citations, an h-index of 11 and an i10-index of 11.
21
Works
598
Citations
11
h-index
11
i10-index
IDs:OpenAlex
How has Ainhoa Oguiza's publication output changed over time?
ScholarIQpublication output · 2012–2024
Output grew0% over the shown period — from 1 works in 2012 to 1 in 2024.
1
1
1
3
1
1
2
1
20122013201420152016201720182024
What are the most-cited papers on Ainhoa Oguiza?
ScholarIQmost cited works
Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice
Iolanda Lázaro, Ainhoa Oguiza, Carlota Recio, Beñat Mallavia, Julio Madrigal‐Matute, Julia Blanco, Jesús Egido, José Luis Martı́n-Ventura, Carmen Gómez‐Guerrero
S129060628. 201594 CitationsOPEN ACCESS
Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
Iolanda Lázaro, Laura Lopez‐Sanz, Susana Bernal, Ainhoa Oguiza, Carlota Recio, Ana Melgar, Luna Jiménez-Castilla, Jesús Egido, Julio Madrigal‐Matute, Carmen Gómez‐Guerrero
Frontiers in Pharmacology. 201872 CitationsOPEN ACCESS
Suppressor of Cytokine Signaling 1–Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice
Carlota Recio, Ainhoa Oguiza, Iolanda Lázaro, Beñat Mallavia, Jesús Egido, Carmen Gómez‐Guerrero
S3485792. 201470 CitationsOPEN ACCESS
SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition
Laura Lopez‐Sanz, Susana Bernal, Carlota Recio, Iolanda Lázaro, Ainhoa Oguiza, Ana Melgar, Luna Jiménez-Castilla, Jesús Egido, Carmen Gómez‐Guerrero
Laboratory Investigation. 201859 CitationsOPEN ACCESS
Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis
Beñat Mallavia, Carlota Recio, Ainhoa Oguiza, Guadalupe Ortiz-Muñoz, Iolanda Lázaro, Virginia López-Parra, Óscar López‐Franco, Susann Schindler, Reinhard Depping, Jesús Egido, Carmen Gómez‐Guerrero
S145577119. 201358 Citations
Related on ScholarIQ
Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice
Paper
Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
Paper
Suppressor of Cytokine Signaling 1–Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice
Paper
SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition
Paper
Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis
Paper
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy
Paper